Calculate MELD, MELD-Na scores and MELD or MELD-Plus score based survival probabilities.
meld(
creatinine,
bilirubin,
inr,
dialysis = FALSE,
cause = "other",
round = FALSE
)
meld_na(
creatinine,
bilirubin,
inr,
sodium,
dialysis = FALSE,
type = c("kim2008", "unos"),
cause = "other",
round = FALSE
)
meld3(
creatinine,
bilirubin,
inr,
sodium,
albumin,
female = TRUE,
round = FALSE
)
pmeld(
meld = NULL,
creatinine,
bilirubin,
inr,
dialysis = FALSE,
cause = "other"
)
pmeld3(meld = NULL, creatinine, bilirubin, inr, sodium, albumin, female)
pmeld_plus7(
creatinine,
bilirubin,
inr,
sodium,
albumin,
wbc,
age,
round = FALSE
)
numeric
, [mg/dl]
numeric
, [mg/dl]
numeric
logical
, had dialysis twice, or 24 hours of CVVHD, within
a week prior to the serum creatinine test?
character
, cause of cirrhosis. Has to be of the same length as
creatinine
, bilirubin
, inr
and dialysis
. Just "ethyltoxic"
,
"cholestatic"
, "unos"
and "other"
are supported.
Use "unos"
for the United Network for Organ Sharing definition of the score.
logical
, round to nearest integer?
numeric
, [mmol/l]
character(1)
, type of implementation
numeric
, [g/dl]
logical
numeric
, MELD/MELD-Na score as calculated by meld
or
meld-na
.
numeric
, [Gpt/l]
numeric
, [years]
numeric
, MELD or MELD-Na score for meld
and meld_na
respectively. pmeld
and pmeld_plus7
return the survival probability based
on the MELD and MELD-Plus7 score.
Laboratory values (creatinine, bilirubin, INR) below 1.0 are set to 1.0 and creatinine above 4.0 is set to 4.0 as described in Wiesner et al. 2003.
The original MELD-Plus risk score reports a mortality probability. To provide
a common interface with pmeld
pmeld_plus7
returns a survival probabilitiy
instead.
Michael Malinchoc et al. 2000. "A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts" Hepatology 31 (4): 864-871. doi:10.1053/he.2000.5852
United Network for Organ Sharing (UNOS). Policy notice 11/2015: OPTN executive committee actions. Available at: https://optn.transplant.hrsa.gov/media/1575/policynotice_20151101.pdf Accessed: September 11, 2019.
Kim et al. 2008. "Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List" N Engl J Med 2008; 359: 1018-1026 doi:10.1056/NEJMoa0801209
Kim et al. 2021. "MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era" Gastroenterology 2021; 161: 1887-1895.e4 doi:10.1053/j.gastro.2021.08.050
Wiesner et al. 2003. "Model for end-stage liver disease (MELD) and allocation of donor livers" Gastroentrology, 124 (1): 91-96 doi:10.1053/gast.2003.50016
Kartoun et al. 2017. "The MELD-Plus: A generalizable prediction risk score in cirrhosis" PloS one, 12 (10): e0186301 doi:10.1371/journal.pone.0186301
meld(creatinine = 1.9, bilirubin = 4.2, inr = 1.2, cause = "other")
#> [1] 20.03916
meld_na(creatinine = 1.9, bilirubin = 4.2, inr = 1.2, sodium = 135)
#> [1] 22.53427
meld_na(creatinine = 1.9, bilirubin = 4.2, inr = 1.2, sodium = 135,
type = "unos")
#> [1] 21.35658
meld3(creatinine = 1.9, bilirubin = 4.2, inr = 1.2, sodium = 135, albumin = 3.5)
#> [1] 23.6327
pmeld(creatinine = 1.9, bilirubin = 4.2, inr = 1.2, cause = "other")
#> [1] 0.923248
pmeld(meld = 20)
#> [1] 0.9237187
pmeld3(meld = 20)
#> [1] 0.947061
pmeld_plus7(2.5, 4.1, 1.2, 137, 24, 6.7, 56)
#> [1] 0.9981954